Accomplished, innovative, strategic, effective

Precision uses novel approaches and methodologies to generate rigorous evidence quantifying the value of health care interventions, to assure these therapies reach patients in need.



Define and implement HEOR strategies that will have the right impact

  • Develop evidence generation strategies to ensure the right information is ready to support the demands of payers
  • Facilitate multi-stakeholder strategic advisory boards and workshops aimed at creating the right evidence package for commercial value demonstration
  • Prepare effective plans and responses to challenges posed by ICER reviews
  • Effectively communicate findings of research through HTA dossiers, scientific publications, white papers, and interactive tools

Leverage state-of-the-art evidence synthesis techniques to overcome gaps in your evidence base

  • Perform systematic literature reviews to gather available evidence
  • Conduct network meta-analysis and population-adjusted indirect comparisons to estimate relative treatment effects in the absence of head-to-head data
  • Use a wide range of approaches to quantify comparative efficacy and safety including generalized and evidence synthesis, validation of surrogate endpoints, and living evidence synthesis

Create credible evidence-based models that capture the drivers of your product’s value

  • Develop core cost effectiveness and budget impact models to support access and reimbursement negotiations
  • Quantify unique sources of individual and societal value through bespoke models and microsimulations
  • Develop decision trees, state-transition, and patient simulation models to address a wide range of questions about treatment value
  • The Health Economics Medical Innovation Simulation (THEMIS) is PRECISIONheor’s tool for assessing long-term social value of medical innovations and healthcare policy changes.

Technical documentation for the simulation is below:

        • The full technical specifications for the model with the HRS as the host dataset can be found here: THEMIS HRS and THEMIS Excel Supplement
        • The original technical specification produced by USC for the Future Elderly Model can be found here: USC FEM
        • The full technical specifications for the model with the PSID as the host dataset can be found here: THEMIS PSID
        • The original technical specification produced by USC for the Future Adult Model can be found here: USC FAM

Leverage a wide range of data assets to generate actionable information

  • Analyze over 50 distinct global retrospective data sources to quantify burden of disease, patient journey, treatment patterns, comparative effectiveness, resource use and costs in order to characterize outcomes of current treatment paradigms
  • Conduct primary data studies including patient preference / discrete choice experiments, utility studies, focus groups, humanistic burden and other surveys to capture critical insights into the patient, caregiver, and provider experience
  • Evaluate the impact of health care policies on patient access, utilization, costs and health outcomes